The immune score as a new possible approach for the classification of cancer, Journal of Translational Medicine, vol.10, issue.1, 2012. ,
DOI : 10.1186/1479-5876-9-32
URL : https://hal.archives-ouvertes.fr/inserm-00664981
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006. ,
DOI : 10.1126/science.1129139
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction, Journal of Clinical Oncology, vol.29, issue.6, pp.610-618, 2011. ,
DOI : 10.1200/JCO.2010.30.5425
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-5951, 2009. ,
DOI : 10.1200/JCO.2008.19.6147
The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012. ,
DOI : 10.1038/nrc3245
Impact of CD68/(CD3+CD20) Ratio at the Invasive Front of Primary Tumors on Distant Metastasis Development in Breast Cancer, PLoS ONE, vol.184, issue.12, p.52796, 2012. ,
DOI : 10.1371/journal.pone.0052796.t004
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy, Cancer Discovery, vol.1, issue.1, pp.54-67, 2011. ,
DOI : 10.1158/2159-8274.CD-10-0028
Immune suppression by melanoma cells as a factor in the generation of metastatic disease, Anticancer Res, vol.9, pp.859-864, 1989. ,
Sentinel Lymph Nodes Show Profound Downregulation of Antigen-Presenting Cells of the Paracortex: Implications for Tumor Biology and Treatment, Modern Pathology, vol.14, issue.6, pp.604-608, 2001. ,
DOI : 10.1038/modpathol.3880358
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma, New England Journal of Medicine, vol.363, issue.8, pp.711-723, 2010. ,
DOI : 10.1056/NEJMoa1003466
Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies, Seminars in Oncology, vol.37, issue.5, pp.508-516, 2010. ,
DOI : 10.1053/j.seminoncol.2010.09.008
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer, Curr Opin Investig Drugs, vol.11, pp.1354-1359, 2011. ,
Science gone translational: the OX40 agonist story, Immunological Reviews, vol.37, issue.1, pp.218-231, 2011. ,
DOI : 10.1111/j.1600-065X.2011.01069.x
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma, Journal of Translational Medicine, vol.9, issue.1, p.204, 2011. ,
DOI : 10.1097/CJI.0b013e31817fd8f3
Safety, Activity, and Immune Correlates of Anti???PD-1 Antibody in Cancer, Sznol M: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, pp.2443-2454, 2012. ,
DOI : 10.1056/NEJMoa1200690
Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types, Clinical Cancer Research, vol.19, issue.5, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-2982
Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling, The American Journal of Pathology, vol.179, issue.1 ,
DOI : 10.1016/j.ajpath.2011.03.007
12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?, Scientific Reports, vol.68, p.765, 2012. ,
DOI : 10.1038/srep00765
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment, Journal of Translational Medicine, vol.11, issue.1, p.54, 2013. ,
DOI : 10.1016/j.ajpath.2011.03.007
URL : https://hal.archives-ouvertes.fr/inserm-00804641